Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

COSCIENS Biopharma Inc T.AEZS

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.


TSX:AEZS - Post by User

Comment by prophetoffactzon Jul 16, 2024 5:49pm
107 Views
Post# 36135682

RE:RE:Still in silent mode...

RE:RE:Still in silent mode...Only about 790,000 shares voted. Didn't take many shares to put someone over the top in the context of outstanding shares. By next year the shareholder base/voting base could be very different given the event horizon as various assets reach proof of principle. That's what the investment community needs along with validating deals and analyst support.    

archeo753 wrote: Anyone know why Dennis Turpin got voted out?  Looks like Ceapro board members were more popular than AEZS board members.  Except for Gilles.

The results of the vote in respect of the election of directors of the Company are set out below:

Name of Nominee Votes For % For Votes Against % Against
Ronald W. Miller (Chair) 668,451 84.64% 121,280 15.36%
Carolyn Egbert 491,197 62.20% 298,534 37.80%
Genevive Foster 667,668 84.54% 122,063 15.46%
Gilles Gagnon 404,154 51.18% 385,577 48.82%
Ulrich Kosciessa 638,832 80.89% 150,899 19.11%
William Li 670,416 84.89% 119,315 15.11%
Dennis Turpin 300,528 38.05% 489,203 61.95%




<< Previous
Bullboard Posts
Next >>